Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
Edvinsson
L
L
D001158:Arteries / Q000294:innervation; D001921:Brain / Q000098:blood supply*; D004388:Dura Mater / Q000098:blood supply*; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin / Q000187:drug effects* / Q000502:physiology; D018170:Sumatriptan / Q000627:therapeutic use*; D012668:Trigeminal Ganglion / Q000187:drug effects* / Q000503:physiopathology
D004876:Ergot Alkaloids; C470302:HTR1B protein, human; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin; D018170:Sumatriptan